 In France, the therapists were quickly directed to a sub-population for which the IPAS could represent a real improvement in the therapeutic management in significantly reducing the number of irradiation sessions of thirty in 6 weeks 5 days at 10 in a single view 6. Several French phase II trials were started specifically targeting the female population aged using a balloon catheter MammoSite 7 or by intra-operative radiation électronthérapie 8. The results of the test using the GERICO-03 brachytherapy with high dose rate promoter: FNCLCC, National Federation of Anti Cancer Centres , recently merged into Group Health Cooperation entitled UNICANCER are currently submitted to Journal Green Radiotherapy Radiotherapy and Oncology from 091111 9. 